LeMaitre Vascular, Inc. (LMAT)
Stock Price:
$29.97 USD
0.31 (1.05%)
Updated Aug 10, 2020 3:12 PM EDT - Market open
Key Info
| Market Cap |
604.85M |
| Revenue (ttm) |
114.67M |
| Net Income (ttm) |
16.47M |
| Shares Out |
20.18M |
| EPS (ttm) |
0.81 |
| PE Ratio |
37.00 |
| Forward PE |
53.19 |
| Dividend |
$0.38 |
| Dividend Yield |
1.27% |
Stock Quote
| Trading Day |
Aug 10, 2020 |
| Last Price |
$29.97 |
| Previous Close |
$29.66 |
| Change ($) |
0.31 |
| Change (%) |
1.05% |
| Day's Open |
29.68 |
| Day's Range |
29.66 - 30.20 |
| Day's Volume |
31,876 |
| 52-Week Range |
18.76 - 38.64 |
More Stats
| Market Cap |
604.85M |
| Enterprise Value |
661.10M |
| Earnings Date (est) |
Oct 21, 2020 |
| Ex-Dividend Date |
May 19, 2020 |
| Shares Outstanding |
20.18M |
| Float |
16.94M |
| EPS (basic) |
0.82 |
| EPS (diluted) |
0.81 |
| FCF / Share |
0.66 |
| Dividend |
$0.38 |
| Dividend Yield |
1.27% |
| Earnings Yield |
2.70% |
| FCF Yield |
2.20% |
| Payout Ratio |
43.90% |
| Shares Short |
1.94M |
| Short Ratio |
15.05 |
| Short % of Float |
14.09% |
| Beta |
1.37 |
| PE Ratio |
37.00 |
| Forward PE |
53.19 |
| P/FCF Ratio |
45.42 |
| PS Ratio |
5.27 |
| PB Ratio |
3.86 |
| Revenue |
114.67M |
| Operating Income |
20.06M |
| Net Income |
16.47M |
| Free Cash Flow |
13.32M |
| Net Cash |
-56.25M |
| Net Cash / Share |
-2.79 |
| Gross Margin |
69.64% |
| Operating Margin |
17.49% |
| Profit Margin |
14.40% |
| FCF Margin |
11.61% |
| ROA |
5.99% |
| ROE |
11.35% |
| ROIC |
17.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (6)
| Buy |
3 |
| Overweight |
0 |
| Hold |
3 |
| Underweight |
0 |
| Sell |
0 |
Analyst Consensus: Overweight
Price Target
$34.50*
(15.12% upside)
Low
30.0
Current: $29.97
High
41.0
Target: 34.50
*Average 12-month price target from 6 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 117 | 106 | 101 | 89.15 | 78.35 | 71.10 | 64.55 | 56.74 | 57.69 | 56.06 |
| Revenue Growth | 11.05% | 4.66% | 13.14% | 13.78% | 10.2% | 10.14% | 13.77% | -1.65% | 2.9% | - |
| Gross Profit | 79.85 | 73.94 | 70.70 | 62.94 | 54.17 | 48.43 | 45.12 | 40.87 | 40.23 | 41.72 |
| Operating Income | 21.18 | 28.21 | 21.10 | 16.34 | 11.15 | 6.34 | 4.52 | 3.99 | 2.96 | 4.02 |
| Net Income | 17.93 | 22.94 | 17.18 | 10.59 | 7.76 | 3.92 | 3.20 | 2.57 | 2.14 | 6.01 |
| Shares Outstanding | 19.81 | 19.43 | 18.96 | 18.49 | 17.76 | 16.61 | 15.32 | 15.19 | 15.46 | 15.63 |
| Earnings Per Share | 0.88 | 1.13 | 0.86 | 0.55 | 0.42 | 0.23 | 0.20 | 0.16 | 0.13 | 0.37 |
| EPS Growth | -22.12% | 31.4% | 56.36% | 30.95% | 82.61% | 15% | 25% | 23.08% | -64.86% | - |
| Dividend Per Share | 0.34 | 0.28 | 0.22 | 0.18 | 0.16 | 0.14 | 0.12 | 0.10 | 0.08 | - |
| Dividend Growth | 21.43% | 27.27% | 22.22% | 12.5% | 14.29% | 16.67% | 20% | 25% | - | - |
| Operating Cash Flow | 14.18 | 19.51 | 22.87 | 16.90 | 11.44 | 5.51 | 5.39 | 4.72 | 3.17 | 7.05 |
| Capital Expenditures | -3.76 | -3.05 | -6.42 | -2.84 | -2.28 | -1.19 | -2.90 | -1.33 | -2.09 | -2.56 |
| Free Cash Flow | 10.42 | 16.45 | 16.45 | 14.05 | 9.16 | 4.32 | 2.49 | 3.40 | 1.09 | 4.49 |
| Cash & Equivalents | 32.68 | 47.99 | 41.66 | 24.29 | 27.45 | 18.69 | 14.71 | 16.45 | 20.13 | 22.61 |
| Total Debt | 15.71 | - | - | - | - | - | - | - | - | - |
| Net Cash / Debt | 16.97 | 47.99 | 41.66 | 24.29 | 27.45 | 18.69 | 14.71 | 16.45 | 20.13 | 22.61 |
| Assets | 188 | 153 | 126 | 102 | 90.70 | 81.49 | 70.49 | 63.06 | 59.69 | 63.27 |
| Liabilities | 40.20 | 22.85 | 16.55 | 14.42 | 12.82 | 13.29 | 13.93 | 10.17 | 7.60 | 10.92 |
| Book Value | 148 | 130 | 110 | 87.50 | 77.88 | 68.21 | 56.56 | 52.89 | 52.09 | 52.36 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
LeMaitre Vascular, Inc. |
| Country |
United States |
| Employees |
454 |
| CEO |
George W. LeMaitre |
Stock Information
| Ticker Symbol |
LMAT |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: LMAT |
| IPO Date |
October 19, 2006 |
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. The company markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.